Risk factors for development of coronary artery disease in women with systemic lupus erythematosus
- PMID: 19833754
- DOI: 10.3899/jrheum.090011
Risk factors for development of coronary artery disease in women with systemic lupus erythematosus
Abstract
Objective: To ascertain coronary artery disease (CAD) outcomes and predictive factors in a prospective study of patients with systemic lupus erythematosus (SLE) and matched healthy controls.
Methods: SLE patients and non-SLE age-matched controls without a history of CAD were recruited into a prospective study between 1997 and 1999. CAD events were assessed at clinic visit for SLE patients and through telephone interview and chart review for controls. All events were verified with patient medical records.
Results: Followup information was available on 237 controls and 241 SLE patients. The mean followup time was 7.2 years. Univariate analyses identified age and postmenopausal status as predictors of CAD in both the groups. Sedentary lifestyle, hypertension, the presence of metabolic syndrome, and the number of Framingham risk factors were predictive in the control group only. The 10-year risk of CAD score was predictive in both groups but was not as marked in the SLE group as in the controls. None of the lipid subfractions were predictive for CAD in the SLE group, whereas in the controls, a high triglyceride level >or= 2.8 was predictive. Time-to-event multivariate analysis for CAD in all subjects revealed SLE itself, older age, and triglycerides >or= 2.8 to be highly predictive for CAD.
Conclusion: In a prospective study of patients with SLE and matched controls followed over a median of 8 years, patients with SLE developed significantly more CAD events than controls. Accounting for demographic variability, CAD risk factors, and lipid factors, SLE is an independent risk factor for the development of CAD.
Comment in
-
Atherosclerosis and lupus: what we know and what we should know.J Rheumatol. 2009 Nov;36(11):2380-2. doi: 10.3899/jrheum.090999. J Rheumatol. 2009. PMID: 19893058 No abstract available.
Similar articles
-
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.Arthritis Rheum. 2006 Jul;54(7):2220-7. doi: 10.1002/art.21967. Arthritis Rheum. 2006. PMID: 16802358
-
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.Arthritis Rheum. 2003 Nov;48(11):3159-67. doi: 10.1002/art.11296. Arthritis Rheum. 2003. PMID: 14613278
-
Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus.J Rheumatol. 1999 Nov;26(11):2363-8. J Rheumatol. 1999. PMID: 10555892
-
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18. Rheumatology (Oxford). 2005. PMID: 16234277 Review.
-
Myocardial infarction in young patients (< or =35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature.Lupus. 2007;16(4):289-97. doi: 10.1177/0961203307078001. Lupus. 2007. PMID: 17439937 Review.
Cited by
-
Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023.Atheroscler Plus. 2024 Feb 17;55:74-92. doi: 10.1016/j.athplu.2024.01.004. eCollection 2024 Mar. Atheroscler Plus. 2024. PMID: 38425675 Free PMC article. Review.
-
Systemic Lupus Erythematosus and Cardiovascular Diseases: A Systematic Review.Cureus. 2023 May 21;15(5):e39284. doi: 10.7759/cureus.39284. eCollection 2023 May. Cureus. 2023. PMID: 37346216 Free PMC article. Review.
-
Development of High Fat Diet-Induced Hyperinsulinemia in Mice Is Enhanced by Co-treatment With a TLR7 Agonist.Front Physiol. 2022 Jul 6;13:930353. doi: 10.3389/fphys.2022.930353. eCollection 2022. Front Physiol. 2022. PMID: 35874527 Free PMC article.
-
Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.Nat Rev Rheumatol. 2022 May;18(5):286-300. doi: 10.1038/s41584-022-00770-y. Epub 2022 Apr 7. Nat Rev Rheumatol. 2022. PMID: 35393604 Review.
-
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.Lupus Sci Med. 2021 May;8(1):e000448. doi: 10.1136/lupus-2020-000448. Lupus Sci Med. 2021. PMID: 34045359 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous